Linked Life Data

19906069

Source:http://linkedlifedata.com/resource/pubmed/id/19906069

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2010-4-28
pubmed:abstractText
Infliximab, a chimeric monoclonal antibody, has been shown to be effective for moderate to severe psoriasis. Clinical experience with long-term infliximab therapy for psoriasis is accumulating, and it is therefore important to share our experience with its use in real-life clinical practice.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1365-2133
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
162
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1117-23
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Infliximab for the treatment of psoriasis in Greece: 4 years of clinical experience at a single centre.
pubmed:affiliation
Department of Dermatology, Andreas Syggros Hospital, University of Athens, Dragoumi 5 Street, 16121, Athens 16121, Greece.
pubmed:publicationType
Journal Article, Case Reports